Denali Therapeutics Inc. Financial Ratios — DNLI Stock

Profitability (USD)

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-7.16	-41.97	9.21	-27.51	-32.52	-14.01	-37.4	-45.69
Return on Assets (%)	- -	-56.31	-23.27	-6.31	-32.52	6.59	-19.32	-22.76	-11.11	-33.45	-40.69
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	7.35	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	100	100	100	100	100	100	- -	- -
EBITDA Margin (%)	- -	- -	- -	-30.16	-769.15	21.23	-590.12	-304.58	-54.45	- -	- -
Operating Margin (%)	- -	- -	- -	-35.9	-799.1	18.69	-607.78	-314.16	-59.51	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	89.29	- -	- -	- -	92.33	- -
Pretax Margin (%)	- -	- -	- -	-28.06	-742.05	21.44	-598.34	-300.54	-43.93	- -	- -
Profit Margin (%)	- -	- -	- -	-28.06	-740.74	21.19	-597.15	-300.56	-43.94	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	-28.06	-740.74	21.19	-597.15	-300.56	-43.94	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	1.14	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-7.16	-41.97	9.21	-27.51	-32.52	-14.01	-37.4	-45.69

Credit (USD)

Credit Ratios API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	73	69	64	60	52	49	37
ST Debt	- -	- -	- -	- -	4	5	5	7	7	12	10
LT Debt	- -	- -	- -	- -	69	64	59	53	45	37	27
Total Debt/EBITDA	- -	- -	- -	- -	-0.35	0.97	-0.22	-0.18	-0.29	-0.1	-0.07
Net Debt/EBITDA	1.86	0.46	2.51	1.98	0.39	-7.12	1.02	0.66	0.71	0.35	0.38
Total Debt/EBIT	- -	- -	- -	- -	-0.34	1.1	-0.22	-0.18	-0.27	-0.1	-0.07
Net Debt/EBIT	1.84	0.46	2.42	1.66	0.37	-8.09	0.99	0.64	0.65	0.35	0.37
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-42.62	-34.73	95.7	82.61	71.38	71.72	68.53	71.39	89.34	89.48	88.55
Long-Term Debt/Equity (%)	- -	- -	- -	- -	17.44	5.58	6.08	5.09	4.36	2.98	2.68
Long-Term Debt/Capital (%)	- -	- -	- -	- -	14.73	5.26	5.71	4.81	4.15	2.87	2.59
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	12.45	4	4.17	3.63	3.9	2.67	2.38
Total Debt/Equity (%)	- -	- -	- -	- -	18.37	5.99	6.65	5.79	5.07	3.96	3.63
Total Debt/Capital (%)	- -	- -	- -	- -	15.52	5.65	6.24	5.47	4.82	3.81	3.5
Total Debt/Total Assets (%)	- -	- -	- -	- -	13.11	4.29	4.56	4.13	4.53	3.54	3.21
Net Debt to Equity	196.62	42.33	-46.88	-14.1	-20.12	-44.08	-30.5	-20.92	-12.33	-14.23	-20.25
Net Debt/Capital (%)	66.29	29.74	-88.26	-16.42	-20.48	-71.2	-40.05	-24.65	-13.29	-15.86	-24.29
EBITDA	-17	-86	-87	-39	-205	71	-287	-330	-180	-493	-541
EBITDA-CapEx	-20	-92	-90	-42	-223	68	-296	-348	-193	-509	-550
Operating Income (Loss)	-17	-87	-90	-46	-213	63	-296	-341	-197	-502	-555

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	8.83	19.58	28.68	14.16	9.16	20.5	2.29	3.67	13.27	8.14	8.82
Current Ratio	9.6	19.98	28.92	14.67	9.48	20.86	2.37	3.77	13.65	8.46	9.16
Quick Ratio	8.83	19.63	28.71	14.42	9.16	20.58	2.29	3.7	13.31	8.16	8.85
CFO/Avg Current Liab	- -	-11.43	-6.59	2.13	-3.88	7.11	-0.94	-0.66	-1.62	-3.86	-4.11
Common Equity/Total Assets	-42.62	-34.73	95.7	82.61	71.38	71.72	68.53	71.39	89.34	89.48	88.55
Long-Term Debt/Equity (%)	- -	- -	- -	- -	17.44	5.58	6.08	5.09	4.36	2.98	2.68
Long-Term Debt/Capital (%)	- -	- -	- -	- -	14.73	5.26	5.71	4.81	4.15	2.87	2.59
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	12.45	4	4.17	3.63	3.9	2.67	2.38
Total Debt/Equity (%)	- -	- -	- -	- -	18.37	5.99	6.65	5.79	5.07	3.96	3.63
Total Debt/Capital (%)	- -	- -	- -	- -	15.52	5.65	6.24	5.47	4.82	3.81	3.5
Total Debt/Total Assets (%)	- -	- -	- -	- -	13.11	4.29	4.56	4.13	4.53	3.54	3.21
CFO/Total Liabilities	-28.77	-19.69	-366.24	43.53	-95.73	91.71	-47.84	-58.57	-291.14	-240.63	-314.74
CFO/CapEx	-4.92	-11.72	-26.66	14.77	-8.46	134.46	-24.87	-13.72	-27.67	-21.85	-43.42
Altman's Z-Score	-1.16	-0.83	39.04	10.49	4.88	14.44	6.55	4.63	13.89	10.1	8.53

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	35.08	7.25	- -	- -	23.37	52.04	- -	- -
Days Sales Outstanding	- -	- -	- -	10.41	50.38	- -	- -	15.62	7.01	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	1,368	1,956	1,676	10,096	5,454	3,781	2,970	2,939	2,579
- Cash & Cash Equivalents	31	40	218	77	79	507	293	218	127	175	205
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	73	69	64	60	52	49	37
Enterprise Value	-31	-178	962	1,491	1,333	8,695	4,652	2,505	1,987	2,156	1,747
Total Capital	-16	-94	466	547	467	1,219	1,026	1,103	1,083	1,278	1,051
Total Debt/Capital (%)	- -	- -	- -	- -	15.52	5.65	6.24	5.47	4.82	3.81	3.5
Total Debt / EV	- -	- -	- -	- -	0.05	0.01	0.01	0.02	0.03	0.02	0.02
EV/Sales	- -	- -	- -	11.55	49.96	25.9	95.61	23.1	6.01	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	122.04	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	138.63	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	29.76	- -	20.89	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	27.87	- -	20.74	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	234	1,914	1,665	9,440	5,420	3,491	2,948	3,352	2,850
Diluted Enterprise Value	-31	-40	16	1,836	1,659	9,002	5,191	3,333	2,873	3,226	2,682
EV per Share	- -	- -	11	15.76	13.86	72.14	38.05	18.43	14.36	14.95	11.19
TTM Sales	- -	- -	- -	129	27	336	49	108	331	- -	- -
TTM EBITDA	-17	-86	-87	-39	-205	71	-287	-330	-180	-493	-541
TTM Operating Income	-17	-87	-90	-46	-213	63	-296	-341	-197	-502	-555
TTM Cash Flow to Firm	-15	-72	-77	50	-152	416	-211	-245	-358	-348	-413
TTM Free Cash Flow to Firm	-12	-66	-74	54	-134	419	-203	-227	-345	-332	-403

Multiples (USD)

Valuation Multiples API ChatGPT

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-3.17	35.76	-12.46	22.52	-26.71	-15.39	-8.54	-10.1	-7.07
EV/EBIT	- -	- -	- -	- -	- -	138.63	- -	- -	- -	- -	- -
Enterprise Value	-31	-178	962	1,491	1,333	8,695	4,652	2,505	1,987	2,156	1,747
Low Price	- -	- -	14.72	12.32	14.24	12.39	41.1	20.24	15.45	14.56	10.57
EV/Sales	- -	- -	- -	11.55	49.96	25.9	95.61	23.1	6.01	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	122.04	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	128.31	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-3.05	-47.3	-9.55	51.9	-24.26	-11.83	-23.82	-8.62	-5.42
Price/Earnings High	- -	- -	-3.89	-65.91	-13.97	143.91	-35.23	-18.28	-31.51	-12.97	-8.2
Price/Earnings Low	- -	- -	-2.5	-31.49	-6.89	18.98	-17.19	-7.79	-14.61	-5.66	-3.56
Price/Book Value	- -	- -	2.94	3.58	4.24	8.77	5.67	3.63	2.88	2.39	2.54
Price/Book Value Average	- -	- -	3.38	3.2	4.81	3.55	7.37	4.01	3.38	2.6	2.48
Price/Book Value High	- -	- -	4.31	4.46	7.03	9.84	10.71	6.19	4.47	3.91	3.75
Price/Book Value Low	- -	- -	2.76	2.13	3.47	1.3	5.22	2.64	2.07	1.71	1.63
Price/Tangible Book Value	- -	- -	2.94	3.58	4.24	8.77	5.67	3.63	2.88	2.39	2.54
Price/Tangible Book Value Average	- -	- -	3.38	3.2	4.81	3.55	7.37	4.01	3.38	2.6	2.48
Price/Tangible Book Value High	- -	- -	4.31	4.46	7.03	9.84	10.71	6.19	4.47	3.91	3.75
Price/Tangible Book Value Low	- -	- -	2.76	2.13	3.47	1.3	5.22	2.64	2.07	1.71	1.63
Price/Sales	- -	- -	- -	14.82	62.43	27.19	111.38	32.19	8.92	- -	- -
Price/Sales Average	- -	- -	- -	13.27	70.76	11	144.89	35.56	10.47	- -	- -
Price/Sales High	- -	- -	- -	18.49	103.45	30.5	210.4	54.93	13.84	- -	- -
Price/Sales Low	- -	- -	- -	8.83	51.03	4.02	102.64	23.42	6.42	- -	- -
Price/Cash Flow	- -	- -	-3.05	38.18	-10.99	21.93	-25.64	-14.27	-8.23	-9.64	-6.91
Price/Cash Flow Average	- -	- -	-3.51	34.2	-12.45	8.87	-33.35	-15.76	-9.66	-10.48	-6.73
Price/Cash Flow High	- -	- -	-4.48	47.66	-18.21	24.6	-48.43	-24.35	-12.78	-15.77	-10.19
Price/Cash Flow Low	- -	- -	-2.87	22.77	-8.98	3.24	-23.63	-10.38	-5.93	-6.89	-4.42
Price/Free Cash Flow Average	- -	- -	-3.65	32.03	-14.12	9.11	-34.75	-17	-10.03	-10.98	-6.89
Price/Free Cash Flow High	- -	- -	-4.66	44.64	-20.65	25.25	-50.46	-26.26	-13.26	-16.52	-10.43
Price/Free Cash Flow Low	- -	- -	-2.99	21.33	-10.19	3.33	-24.62	-11.2	-6.15	-7.22	-4.53
EV/Sales Average	- -	- -	- -	12.97	70.93	10.86	141.08	37.07	10.32	- -	- -
EV/Sales High	- -	- -	- -	18.3	103.82	32.43	207	58.05	13.72	- -	- -
EV/Sales Low	- -	- -	- -	8.43	51.08	3.14	98.57	23.92	6.24	- -	- -
EV/EBITDA Average	1.86	0.46	-15.55	-42.99	-9.22	51.16	-23.91	-12.17	-18.95	-6.22	-4.34
EV/EBITDA High	1.86	0.46	-20.55	-60.69	-13.5	152.77	-35.08	-19.06	-25.2	-9.5	-6.72
EV/EBITDA Low	1.86	0.46	-12.28	-27.96	-6.64	14.81	-16.7	-7.85	-11.46	-4	-2.74
EV/EBIT Average	1.84	0.46	-15.02	-36.11	-8.88	58.12	-23.21	-11.8	-17.34	-6.11	-4.22
EV/EBIT High	1.84	0.46	-19.85	-50.98	-12.99	173.55	-34.06	-18.48	-23.05	-9.33	-6.54
EV/EBIT Low	1.84	0.46	-11.86	-23.49	-6.39	16.82	-16.22	-7.61	-10.49	-3.93	-2.67
Last Price	- -	- -	15.64	20.66	17.42	83.76	44.6	27.81	21.46	20.38	16.51
High Price	- -	- -	22.95	25.79	28.86	93.94	84.25	47.46	33.31	33.33	24.35
Enterprise Value Average	-31	-40	1,354	1,675	1,892	3,645	6,865	4,020	3,410	3,068	2,344
Enterprise Value High	-31	-40	1,789	2,364	2,770	10,884	10,073	6,296	4,535	4,681	3,634
Enterprise Value Low	-31	-40	1,069	1,089	1,363	1,055	4,796	2,594	2,063	1,974	1,482

Shares Outstanding	82	82	87	95	96	121	122	136	138	144	156
Diluted Weighted Avg Shares	3	6	15	93	96	113	122	126	137	164	173
Basic Weighted Avg Shares	3	6	15	93	96	109	122	126	137	164	173
Revenue per Share	- -	- -	- -	1.39	0.28	3.08	0.4	0.86	2.41	- -	- -
EBITDA per Share	-5.51	-13.38	-5.82	-0.42	-2.15	0.65	-2.36	-2.63	-1.31	-3	-3.13
Operating Income per Share	-5.55	-13.61	-6.02	-0.5	-2.23	0.58	-2.43	-2.71	-1.43	-3.05	-3.22
Basic EPS, GAAP	-5.58	-13.49	-5.89	-0.39	-2.07	0.65	-2.39	-2.6	-1.06	-2.57	-2.97
Basic EPS from Cont Ops	-5.58	-13.49	-5.89	-0.39	-2.07	0.65	-2.39	-2.6	-1.06	-2.57	-2.97
Diluted EPS, GAAP	-5.58	-13.49	-5.89	-0.39	-2.07	0.63	-2.39	-2.6	-1.06	-2.57	-2.97
Diluted EPS from Cont Ops	-5.58	-13.49	-5.89	-0.39	-2.07	0.63	-2.39	-2.6	-1.06	-2.57	-2.97
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-5.01	-11.19	-5.12	0.54	-1.59	3.82	-1.74	-1.95	-2.61	-2.11	-2.39
Free Cash Flow per Basic Share	-6.03	-12.15	-5.31	0.5	-1.77	3.79	-1.81	-2.09	-2.7	-2.21	-2.44
Cash & Equivalents per Share	0.37	2.16	4.64	4.9	4.32	12.19	7.08	9.83	7.48	5.77	5.56
Book Value per Share	-0.19	-1.14	5.32	5.78	4.11	9.55	7.87	7.67	7.45	8.53	6.49
Tangible Book Value per Share	-0.19	-1.14	5.32	5.78	4.11	9.55	7.87	7.67	7.45	8.53	6.49

Denali Therapeutics Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)